WASHINGTON (Sputnik) – The US government has signed a $138 million contract with a syringe and injector-making company to boost domestic production capacity in making devices to deal with the coronavirus (COVID-19) crisis, the Department of Defence said in a statement.
Andrews said the deal will dramatically expand US production capability for domestically manufactured, medical-grade injection devices starting by October of this year.
The contract also enables ApiJect Systems America to accelerate the launch of the RAPID USA manufactured in new and permanent US-based facilities with the goal of producing over 500 million prefilled syringes in 2021, the statement added.
As of 12 May, the United States has more than 1.34 million confirmed cases of COVID-19 and around 81,000 deaths caused by the disease, according to data assembled by the US Centres for Disease Control and Prevention.
Sourse: sputniknews.com
0.00 (0%) 0 votes
MOSCOW (Sputnik) - The Coalition for the Restoration of Democracy (CORED), which unites 18 opposition parties in Guinea, said on…
The news of an interplanetary scale comes after NASA believed it had captured its first sample with Perseverance last month,…
MOSCOW (Sputnik) - The last pipe of the second string of Nord Stream 2 has been welded, and after a…
LONDON (Sputnik) – The UK government on Monday condemned the military coup against the president of Guinea, Alpha Conde, and…